IP Library Granted Patent US 10,131,631
Granted Patent B2
US 10,131,631 · App. 15/455,932 · Granted Nov 20, 2018

Patent

Inventors: Michael Einziger (Malibu, CA); Ann Marie Simpson (Malibu, CA)
C07D209/12A61K8/492A61Q19/02C07D487/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,131,631
App. No.
15/455,932
Granted
Nov 20, 2018
Kind
B2
Abstract

The present invention relates to compounds, compositions, and methods for brightening skin. The compounds, compositions, and methods of the present invention generally involve compounds produced by a Malassezia yeast, and chemical analogs thereof. In addition to skin brightening applications, the compounds, compositions, and methods of the present invention may be used to modulate melanocyte activity, induce melanocyte apoptosis, agonize an arylhydrocarbon receptor (AhR), improve hyperpigmentation caused by a hyperpigmentation disorder, and modulate melanin production, melanosome biogenesis, and melanosome transfer.

Claims (16)

1. A method for brightening skin in a subject comprising:

contacting the subject with a compound having the structure of formula (II):

wherein:

R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, and R11 are independently selected from the group consisting of hydrogen and methyl;

or a hydrate or cosmetically or pharmaceutically acceptable salt thereof.

2. The method of claim 1 , wherein the compound is selected from the group consisting of:

3. A method for inducing melanocyte apoptosis in a subject comprising:

contacting the subject with a compound having the structure of formula (II):

wherein:

R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, and R11 are independently selected from the group consisting of hydrogen and methyl;

or a hydrate or cosmetically or pharmaceutically acceptable salt thereof.

4. The method of claim 3 , wherein the compound is selected from the group consisting of:

5. The method of claim 1 , wherein the subject is contacted with a pharmaceutically acceptable salt of the compound having the structure of formula (II).

6. The method of claim 1 , wherein the subject is contacted with a cosmetically acceptable salt of the compound having the structure of formula (II).

7. The method of claim 3 , wherein the subject is contacted with a pharmaceutically acceptable salt of the compound having the structure of formula (II).

8. The method of claim 3 , wherein the subject is contacted with a cosmetically acceptable salt of the compound having the structure of formula (II).

Assignments (2)
SECURITY INTEREST Recorded Jun 1, 2026
From: VERSICOLOR TECHNOLOGIES, LLC
To: WESTERN ALLIANCE BANK
Reel/Frame 074810/0722 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2019
From: EINZIGER, MICHAEL; SIMPSON, ANN MARIE
To: VERSICOLOR TECHNOLOGIES, LLC
Reel/Frame 050959/0905 →
Continuity (2)
Provisional Application 62306468 · Mar 10, 2016
Related Publication 20170260133A1 · Sep 14, 2017
Cited By (3)
US 12,428,374 US 12,458,577 US 12,497,385